Yahoo Web Search

Search results

1. • 

     Eli Lilly beefs up plan to expand manufacturing for popular drugs Zepbound, Mounjaro

     WCMH Columbus· 7 days ago

     Eli Lilly will spend more than $5 billion to expand an Indiana manufacturing site and eventually...

2. • 

     Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It

     Zacks via Yahoo Finance· 3 days ago

     Eli Lilly (LLY) has recently been on Zacks.com's list of the most searched stocks. Therefore, you...

3. • 

     Costco, Eli Lilly Near New Highs; That Doesn't Scare Mutual Funds

     Investor's Business Daily· 17 hours ago

     Lilly Stock Near Record Highs IBD Leaderboard drug stock Eli Lilly is in a buy zone up to 833.35 of...

4. • 

     Eli Lilly to spend $5.3 billion to boost Zepbound, Mounjaro manufacturing

     Market Watch· 7 days ago

     Eli Lilly & Co. said Friday that it has more than doubled its investment in a Lebanon, Ind., site to...

5. • 

     Could Eli Lilly Be the Next to Join the Trillion-Dollar Club?

     Motley Fool via Yahoo Finance· 2 days ago

     So these waiting-in-the-wings candidates could drive future growth if all goes smoothly. And, as...

6. • 

     Lilly's huge expansion plan took place at record speed to reduce bottlenecks for Mounjaro, Zepbound...

     Indianapolis Business Journal· 7 days ago

     Eli Lilly and Co.’s decision to invest another $5.3 billion in its Boone County manufacturing...

7. • 

     Lilly to invest another $5.3B in Lebanon site to meet overwhelming demand for Mounjaro, Zepbound -...

     Indianapolis Business Journal· 7 days ago

     Faced with overwhelming demand for its diabetes treatment Mounjaro and weight-loss treatment...

8. • 

     Ozempic-Maker Novo Nordisk Sues Pharmacies And Weight Loss Clinics For Allegedly Selling Impure...

     Forbes· 1 day ago

     Novo Nordisk has filed nine lawsuits against medical spas, wellness clinics and pharmacies for...

9. • 

     3 High-Flying Stocks That Could Soar Even More

     Motley Fool via Yahoo Finance· 6 days ago

     Given all that, it looks like Vertex Pharmaceuticals isn't finished delivering above-average returns. The biotech still has plenty of upside left. Should...

10. • 

      Lilly to pour $5B more into expanding Zepbound, Mounjaro production

      BioPharma Dive via Yahoo Finance· 7 days ago

      The planned spending on new facilities in Lebanon, Indiana, brings its total commitment to the site...